Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Drug Eluting Balloons (DEB) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4669635
    • |
  • 10 February, 2026
    • |
  • Global
    • |
  • 121 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Drug Eluting Balloons (DEB) market size was valued at US$ 1564 million in 2025 and is forecast to a readjusted size of US$ 3556 million by 2032 with a CAGR of 12.3% during review period.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. In 2025, global drug-eluting balloon production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
This report is a detailed and comprehensive analysis for global Drug Eluting Balloons (DEB) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Eluting Balloons (DEB) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloons (DEB) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloons (DEB) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloons (DEB) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Eluting Balloons (DEB)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Eluting Balloons (DEB) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drug Eluting Balloons (DEB) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Peripheral DEBs
Coronary DEBs
Market segment by Use Scenario
In-Stent Restenosi
De Novo
Small Vessel
Market segment by Balloon Platform Mechanics
Semi-/Compliant
Non-compliant
Other
Market segment by Application
Catheterization Laboratory
Hospital
Others
Major players covered
B. Braun
Medtronic
Boston Scientific
BD
Yinyi Biotechnology
Acotec
Philips
Lepu Medical
Eurocor
MicroPort Medical
Teleflex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Balloons (DEB) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Balloons (DEB), with price, sales quantity, revenue, and global market share of Drug Eluting Balloons (DEB) from 2021 to 2026.
Chapter 3, the Drug Eluting Balloons (DEB) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Balloons (DEB) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug Eluting Balloons (DEB) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Balloons (DEB).
Chapter 14 and 15, to describe Drug Eluting Balloons (DEB) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug Eluting Balloons (DEB) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Peripheral DEBs
    • 1.3.3 Coronary DEBs
  • 1.4 Market Analysis by Use Scenario
    • 1.4.1 Overview: Global Drug Eluting Balloons (DEB) Consumption Value by Use Scenario: 2021 Versus 2025 Versus 2032
    • 1.4.2 In-Stent Restenosi
    • 1.4.3 De Novo
    • 1.4.4 Small Vessel
  • 1.5 Market Analysis by Balloon Platform Mechanics
    • 1.5.1 Overview: Global Drug Eluting Balloons (DEB) Consumption Value by Balloon Platform Mechanics: 2021 Versus 2025 Versus 2032
    • 1.5.2 Semi-/Compliant
    • 1.5.3 Non-compliant
    • 1.5.4 Other
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Drug Eluting Balloons (DEB) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Catheterization Laboratory
    • 1.6.3 Hospital
    • 1.6.4 Others
  • 1.7 Global Drug Eluting Balloons (DEB) Market Size & Forecast
    • 1.7.1 Global Drug Eluting Balloons (DEB) Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Drug Eluting Balloons (DEB) Sales Quantity (2021-2032)
    • 1.7.3 Global Drug Eluting Balloons (DEB) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 B. Braun
    • 2.1.1 B. Braun Details
    • 2.1.2 B. Braun Major Business
    • 2.1.3 B. Braun Drug Eluting Balloons (DEB) Product and Services
    • 2.1.4 B. Braun Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 B. Braun Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Drug Eluting Balloons (DEB) Product and Services
    • 2.2.4 Medtronic Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 Boston Scientific
    • 2.3.1 Boston Scientific Details
    • 2.3.2 Boston Scientific Major Business
    • 2.3.3 Boston Scientific Drug Eluting Balloons (DEB) Product and Services
    • 2.3.4 Boston Scientific Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boston Scientific Recent Developments/Updates
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Drug Eluting Balloons (DEB) Product and Services
    • 2.4.4 BD Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BD Recent Developments/Updates
  • 2.5 Yinyi Biotechnology
    • 2.5.1 Yinyi Biotechnology Details
    • 2.5.2 Yinyi Biotechnology Major Business
    • 2.5.3 Yinyi Biotechnology Drug Eluting Balloons (DEB) Product and Services
    • 2.5.4 Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Yinyi Biotechnology Recent Developments/Updates
  • 2.6 Acotec
    • 2.6.1 Acotec Details
    • 2.6.2 Acotec Major Business
    • 2.6.3 Acotec Drug Eluting Balloons (DEB) Product and Services
    • 2.6.4 Acotec Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Acotec Recent Developments/Updates
  • 2.7 Philips
    • 2.7.1 Philips Details
    • 2.7.2 Philips Major Business
    • 2.7.3 Philips Drug Eluting Balloons (DEB) Product and Services
    • 2.7.4 Philips Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Philips Recent Developments/Updates
  • 2.8 Lepu Medical
    • 2.8.1 Lepu Medical Details
    • 2.8.2 Lepu Medical Major Business
    • 2.8.3 Lepu Medical Drug Eluting Balloons (DEB) Product and Services
    • 2.8.4 Lepu Medical Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Lepu Medical Recent Developments/Updates
  • 2.9 Eurocor
    • 2.9.1 Eurocor Details
    • 2.9.2 Eurocor Major Business
    • 2.9.3 Eurocor Drug Eluting Balloons (DEB) Product and Services
    • 2.9.4 Eurocor Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Eurocor Recent Developments/Updates
  • 2.10 MicroPort Medical
    • 2.10.1 MicroPort Medical Details
    • 2.10.2 MicroPort Medical Major Business
    • 2.10.3 MicroPort Medical Drug Eluting Balloons (DEB) Product and Services
    • 2.10.4 MicroPort Medical Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MicroPort Medical Recent Developments/Updates
  • 2.11 Teleflex
    • 2.11.1 Teleflex Details
    • 2.11.2 Teleflex Major Business
    • 2.11.3 Teleflex Drug Eluting Balloons (DEB) Product and Services
    • 2.11.4 Teleflex Drug Eluting Balloons (DEB) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Teleflex Recent Developments/Updates

3 Competitive Environment: Drug Eluting Balloons (DEB) by Manufacturer

  • 3.1 Global Drug Eluting Balloons (DEB) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Drug Eluting Balloons (DEB) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Drug Eluting Balloons (DEB) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Drug Eluting Balloons (DEB) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Drug Eluting Balloons (DEB) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Drug Eluting Balloons (DEB) Manufacturer Market Share in 2025
  • 3.5 Drug Eluting Balloons (DEB) Market: Overall Company Footprint Analysis
    • 3.5.1 Drug Eluting Balloons (DEB) Market: Region Footprint
    • 3.5.2 Drug Eluting Balloons (DEB) Market: Company Product Type Footprint
    • 3.5.3 Drug Eluting Balloons (DEB) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug Eluting Balloons (DEB) Market Size by Region
    • 4.1.1 Global Drug Eluting Balloons (DEB) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Drug Eluting Balloons (DEB) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Drug Eluting Balloons (DEB) Average Price by Region (2021-2032)
  • 4.2 North America Drug Eluting Balloons (DEB) Consumption Value (2021-2032)
  • 4.3 Europe Drug Eluting Balloons (DEB) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Drug Eluting Balloons (DEB) Consumption Value (2021-2032)
  • 4.5 South America Drug Eluting Balloons (DEB) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Drug Eluting Balloons (DEB) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 5.2 Global Drug Eluting Balloons (DEB) Consumption Value by Type (2021-2032)
  • 5.3 Global Drug Eluting Balloons (DEB) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 6.2 Global Drug Eluting Balloons (DEB) Consumption Value by Application (2021-2032)
  • 6.3 Global Drug Eluting Balloons (DEB) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 7.2 North America Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 7.3 North America Drug Eluting Balloons (DEB) Market Size by Country
    • 7.3.1 North America Drug Eluting Balloons (DEB) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Drug Eluting Balloons (DEB) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Drug Eluting Balloons (DEB) Market Size by Country
    • 8.3.1 Europe Drug Eluting Balloons (DEB) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Drug Eluting Balloons (DEB) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Drug Eluting Balloons (DEB) Market Size by Region
    • 9.3.1 Asia-Pacific Drug Eluting Balloons (DEB) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Drug Eluting Balloons (DEB) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 10.2 South America Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 10.3 South America Drug Eluting Balloons (DEB) Market Size by Country
    • 10.3.1 South America Drug Eluting Balloons (DEB) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Drug Eluting Balloons (DEB) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Drug Eluting Balloons (DEB) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Drug Eluting Balloons (DEB) Market Size by Country
    • 11.3.1 Middle East & Africa Drug Eluting Balloons (DEB) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Drug Eluting Balloons (DEB) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Drug Eluting Balloons (DEB) Market Drivers
  • 12.2 Drug Eluting Balloons (DEB) Market Restraints
  • 12.3 Drug Eluting Balloons (DEB) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug Eluting Balloons (DEB) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug Eluting Balloons (DEB)
  • 13.3 Drug Eluting Balloons (DEB) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug Eluting Balloons (DEB) Typical Distributors
  • 14.3 Drug Eluting Balloons (DEB) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Drug Eluting Balloons (DEB). Industry analysis & Market Report on Drug Eluting Balloons (DEB) is a syndicated market report, published as Global Drug Eluting Balloons (DEB) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Drug Eluting Balloons (DEB) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo